Clinical trial
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of…
NCT00248170 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00248170 |
|---|---|
| Title | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer |
| Official title | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer |
| Acronym | FACE |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Letrozole, Anastrozole |
| Enrollment | 4,172 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Nov 3, 2005 |
| Last update posted | Apr 19, 2016 |
| Countries | Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Ireland, Israel, Italy, Japan and 8 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: